These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25312015)

  • 21. Suitability of capillary blood for quantitative assessment of G6PD activity and performances of G6PD point-of-care tests.
    Bancone G; Chu CS; Chowwiwat N; Somsakchaicharoen R; Wilaisrisak P; Charunwatthana P; Bansil P; McGray S; Domingo GJ; Nosten FH
    Am J Trop Med Hyg; 2015 Apr; 92(4):818-824. PubMed ID: 25646252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the CareStart™ glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in the field settings and assessment of perceived risk from primaquine at the community level in Cambodia.
    Wojnarski B; Lon C; Sea D; Sok S; Sriwichai S; Chann S; Hom S; Boonchan T; Ly S; Sok C; Nou S; Oung P; Kong N; Pheap V; Thay K; Dao V; Kuntawunginn W; Feldman M; Gosi P; Buathong N; Ittiverakul M; Uthaimongkol N; Huy R; Spring M; Lek D; Smith P; Fukuda MM; Wojnarski M
    PLoS One; 2020; 15(1):e0228207. PubMed ID: 32004348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of the CareStart glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in Gressier, Haiti.
    von Fricken ME; Weppelmann TA; Eaton WT; Masse R; Beau de Rochars MV; Okech BA
    Am J Trop Med Hyg; 2014 Jul; 91(1):77-80. PubMed ID: 24778197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania.
    Djigo OKM; Bollahi MA; Hasni Ebou M; Ould Ahmedou Salem MS; Tahar R; Bogreau H; Basco L; Ould Mohamed Salem Boukhary A
    PLoS One; 2019; 14(9):e0220977. PubMed ID: 31525211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucose-6-phosphate dehydrogenase deficiency and malaria: cytochemical detection of heterozygous G6PD deficiency in women.
    Peters AL; Van Noorden CJ
    J Histochem Cytochem; 2009 Nov; 57(11):1003-11. PubMed ID: 19546473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report.
    von Seidlein L; Auburn S; Espino F; Shanks D; Cheng Q; McCarthy J; Baird K; Moyes C; Howes R; Ménard D; Bancone G; Winasti-Satyahraha A; Vestergaard LS; Green J; Domingo G; Yeung S; Price R
    Malar J; 2013 Mar; 12():112. PubMed ID: 23537118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. G6PD deficiency at Sumba in Eastern Indonesia is prevalent, diverse and severe: implications for primaquine therapy against relapsing Vivax malaria.
    Satyagraha AW; Sadhewa A; Baramuli V; Elvira R; Ridenour C; Elyazar I; Noviyanti R; Coutrier FN; Harahap AR; Baird JK
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003602. PubMed ID: 25746733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modification to reporting of qualitative fluorescent spot test results improves detection of glucose-6-phosphate dehydrogenase (G6PD)-deficient heterozygote female newborns.
    Nadarajan V; Shanmugam H; Sthaneshwar P; Jayaranee S; Sultan KS; Ang C; Arumugam S
    Int J Lab Hematol; 2011 Oct; 33(5):463-70. PubMed ID: 21501392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms.
    Baird JK; Battle KE; Howes RE
    Malar J; 2018 Jan; 17(1):42. PubMed ID: 29357870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of G6PD deficiency in Thai blood donors, the characteristics of G6PD deficient blood, and the efficacy of fluorescent spot test to screen for G6PD deficiency in a hospital blood bank setting.
    Rojphoung P; Rungroung T; Siriboonrit U; Vejbaesya S; Permpikul P; Kittivorapart J
    Hematology; 2022 Dec; 27(1):208-213. PubMed ID: 35134307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review and drug therapy implications of glucose-6-phosphate dehydrogenase deficiency.
    Belfield KD; Tichy EM
    Am J Health Syst Pharm; 2018 Feb; 75(3):97-104. PubMed ID: 29305344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reference and point-of-care testing for G6PD deficiency: Blood disorder interference, contrived specimens, and fingerstick equivalence and precision.
    Pal S; Myburgh J; Bansil P; Hann A; Robertson L; Gerth-Guyette E; Ambler G; Bizilj G; Kahn M; Zobrist S; Manis MR; Styke NA; Allan V; Ansbro R; Akingbade T; Bryan A; Murphy SC; Kublin JG; Layton M; Domingo GJ
    PLoS One; 2021; 16(9):e0257560. PubMed ID: 34543346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of primaquine in malaria infected patients with red cell glucose-6-phosphate dehydrogenase (G6PD) deficiency in Myanmar.
    Myat-Phone-Kyaw ; Myint-Oo ; Aung-Naing ; Aye-Lwin-Htwe
    Southeast Asian J Trop Med Public Health; 1994 Dec; 25(4):710-3. PubMed ID: 7667719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of CareStart G6PD rapid diagnostic test and CareStart G6PD biosensor in Mauritania.
    Djigo OKM; Ould Khalef Y; Ould Ahmedou Salem MS; Gomez N; Basco L; Briolant S; Ould Mohamed Salem Boukhary A
    Infect Dis Poverty; 2021 Aug; 10(1):105. PubMed ID: 34353361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic performances of the fluorescent spot test for G6PD deficiency in newborns along the Thailand-Myanmar border: A cohort study.
    Thielemans L; Gornsawun G; Hanboonkunupakarn B; Paw MK; Porn P; Moo PK; Van Overmeire B; Proux S; Nosten F; McGready R; Carrara VI; Bancone G
    Wellcome Open Res; 2018; 3():1. PubMed ID: 29552643
    [No Abstract]   [Full Text] [Related]  

  • 36. Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens.
    Chu CS; Bancone G; Moore KA; Win HH; Thitipanawan N; Po C; Chowwiwat N; Raksapraidee R; Wilairisak P; Phyo AP; Keereecharoen L; Proux S; Charunwatthana P; Nosten F; White NJ
    PLoS Med; 2017 Feb; 14(2):e1002224. PubMed ID: 28170391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of phenotypic and genotypic G6PD deficiency on risk of plasmodium vivax infection: a case-control study amongst Afghan refugees in Pakistan.
    Leslie T; Briceño M; Mayan I; Mohammed N; Klinkenberg E; Sibley CH; Whitty CJ; Rowland M
    PLoS Med; 2010 May; 7(5):e1000283. PubMed ID: 20520804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Profile of Glucose-6-Phosphate Dehydrogenase Variants and Deficiency of Multicultural Families in Korea.
    Bahk YY; Ahn SK; Lee J; Im JH; Yeom JS; Park S; Kwon J; Kan H; Kim M; Jang W; Kim TS
    Korean J Parasitol; 2021 Oct; 59(5):447-455. PubMed ID: 34724763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementation of G6PD testing and primaquine for
    Kitchakarn S; Lek D; Thol S; Hok C; Saejeng A; Huy R; Chinanonwait N; Thimasarn K; Wongsrichanalai C
    WHO South East Asia J Public Health; 2017 Sep; 6(2):60-68. PubMed ID: 28857064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of primaquine in malaria control and elimination in French-speaking Africa].
    Briolant S; Pradines B; Basco LK
    Bull Soc Pathol Exot; 2017 Aug; 110(3):198-206. PubMed ID: 28417346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.